Skip to content

Application of Enhanced Recovery after Surgery (ERAS) Principles in Nursing Care for Robot-Assisted Radical Cystectomy

Application of Enhanced Recovery after Surgery (ERAS) Principles in Nursing Care for Robot-Assisted Radical Cystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081118
Enrollment
Unknown
Registered
2024-02-22
Start date
2024-02-29
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

Enhanced Recovery after Surgery (ERAS):Nursing model based on the concept of ERAS
control group:Nursing model based on the concept of traditional nursing

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with invasive bladder urothelial carcinoma based on preoperative imaging, cystoscopy biopsy, or diagnostic bladder electroresection, with no evidence of systemic organ metastasis; 2) undergoing complete robot-assisted STAPLER method radical cystectomy, standard pelvic lymph node dissection, and in situ ileal U-shaped neobladder construction and all surgical procedures performed using the robot-assisted surgical system; 3) Absence of a history of external radiation therapy or intravenous chemotherapy before surgery, and no history of traditional open abdominal surgery; 4) Normal body temperature within the last 3 days and upon admission; 5) and color doppler ultrasound confirming unobstructed venous blood flow in the lower extremities before anesthesia.

Exclusion criteria

Exclusion criteria: 1) Intraoperative change of surgical approach to laparoscopy or open surgery; 2) History of venous thromboembolism (VTE) and prior anticoagulant or thrombolytic therapy before surgery; 3) Cardiovascular conditions prone to thrombosis, such as atrial fibrillation, congestive heart failure, pulmonary edema, etc.; 4) Disorders related to temperature regulation and metabolism; 5) Abnormalities in the local condition of the lower limbs, including swelling, gangrene, dermatitis, prior skin graft surgery, severe lower limb deformities, and ischemic vascular diseases like arterial sclerosis; 6) Transfusion of blood products during surgery; 7) Incomplete surgical data.

Design outcomes

Primary

MeasureTime frame
the rate of unobstructed venous blood flow in the lower extremities by color Doppler Ultrasound during postoperative period;

Secondary

MeasureTime frame
degree of preoperative anxiety score and surgical information demand score;Duration of surgery;the rate of introperative blood loss;the rate of introperative hypothermia;

Countries

China

Contacts

Public ContactHE Mangmang

Zhejiang Provincial People’s Hospital

270648319@qq.com+86 188 5789 8085

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026